COMPARATIVE IMMUNOHISTOCHEMICAL EVALUATION OF E-CADHERIN AND Β-KATENIN EXPRESSION IN METASTATIC AND NON-METASTATIC BREAST CANCER OF NON-SPECIFIC TYPE
- Authors: Mnikhovich M.V.1,2, Kakturskiy L.V.1,2, Bezuglova T.V.1, Midiber K.Y.3, Bun’kov K.V.4, Erzieva A.G.5
-
Affiliations:
- Research Institute of Human Morphology
- N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
- City Clinical Hospital No. 31, Moscow Healthcare Department
- Smolensk Regional Institute of Pathology
- A.K. Eramishantsev City Clinical Hospital, Moscow Healthcare Department
- Issue: Vol 14, No 2 (2018)
- Pages: 14-20
- Section: MAMMOLOGY. ORIGINAL REPORTS
- Published: 15.08.2018
- URL: https://ojrs.abvpress.ru/ojrs/article/view/590
- DOI: https://doi.org/10.17650/1994-4098-2018-14-2-14-20
- ID: 590
Cite item
Full Text
Abstract
Objective: an immunohistochemical analysis of the features of expression, distribution and interaction of E-сadherin and β-сatenin proteins in primary mammary tumors.
Materials and methods. The study group consisted of 148 relevant patients with breast cancer (BC), including patients with metastases in lymph nodes (n = 12) and liver (n = 45). E-сadherin and β-сatenin expression on BC cells was determined using immunohistochemical method with specific antibodies.
Results. It was shown that the reduction and the total absence of E-сadherin expression was observed much more often in patients with BC with metastases in liver, than in patients without metastases (70 % of cases versus 30 % of cases respectively). An increase of cytoplasmic immune reactivity and a nuclear translocation of β-сatenin are found in more than 80 % cases of BC with metastases.
Conclusion. The changes in the expression of E-сadherin and β-сatenin in tumor cell can be considered as factors of a non-favorable prognosis of BC. The emergence of β-сatenin expression indicates the activation of a signaling pathway which is triggered by the aberrant expression of epithelial cadherins leading to an increased mobility and invasion of tumor cells.
About the authors
M. V. Mnikhovich
Research Institute of Human Morphology;N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
Author for correspondence.
Email: mnichmaxim@yandex.ru
3 Tsyuryupy St., Moscow, 1174184
1 Ostrovityanova St., Moscow 117997
Russian FederationL. V. Kakturskiy
Research Institute of Human Morphology;N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
3 Tsyuryupy St., Moscow, 117418
1 Ostrovityanova St., Moscow 117997
Russian FederationT. V. Bezuglova
Research Institute of Human Morphology117418 Москва, ул. Цюрупы, 3 Russian Federation
K. Yu. Midiber
City Clinical Hospital No. 31, Moscow Healthcare Department42 Lobachevskogo St., Moscow 119415 Russian Federation
K. V. Bun’kov
Smolensk Regional Institute of Pathology27 Prospekt Gagarina, Smolensk 214018 Russian Federation
A. G. Erzieva
A.K. Eramishantsev City Clinical Hospital, Moscow Healthcare Department15 Lenskaya St., Moscow 129327 Russian Federation
References
Supplementary files

